Best practices for reporting throughput in biomedical research
Nat Methods
.
2022 Jun;19(6):633-634.
doi: 10.1038/s41592-022-01483-6.
Authors
Maik Herbig
#
1
,
Akihiro Isozaki
#
1
,
Dino Di Carlo
2
3
4
,
Jochen Guck
5
6
,
Nao Nitta
7
,
Robert Damoiseaux
2
3
8
,
Shogo Kamikawaji
9
,
Eigo Suyama
9
,
Hirofumi Shintaku
10
,
Angela Ruohao Wu
11
12
,
Itoshi Nikaido
13
14
15
,
Keisuke Goda
16
17
18
Affiliations
1
Department of Chemistry, The University of Tokyo, Tokyo, Japan.
2
Department of Bioengineering, University of California, Los Angeles, Los Angeles, CA, USA.
3
California NanoSystems Institute, University of California, Los Angeles, Los Angeles, CA, USA.
4
Department of Mechanical Engineering, University of California, Los Angeles, Los Angeles, CA, USA.
5
Max Planck Institute for the Science of Light, Erlangen, Germany.
6
Max-Planck-Zentrum für Physik und Medizin, Erlangen, Germany.
7
CYBO, Inc., Tokyo, Japan.
8
Department of Molecular and Medicinal Pharmacology, University of California, Los Angeles, Los Angeles, CA, USA.
9
Chugai Pharmaceutical Co., Ltd., Tokyo, Japan.
10
RIKEN Cluster for Pioneering Research, Saitama, Japan.
11
Division of Life Science, The Hong Kong University of Science and Technology, Hong Kong SAR, China.
12
Department of Chemical and Biological Engineering, The Hong Kong University of Science and Technology, Hong Kong SAR, China.
13
RIKEN Center for Biosystems Dynamics Research, Saitama, Japan.
14
Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan.
15
Graduate School of Science and Technology, University of Tsukuba, Saitama, Japan.
16
Department of Chemistry, The University of Tokyo, Tokyo, Japan. goda@chem.s.u-tokyo.ac.jp.
17
Department of Bioengineering, University of California, Los Angeles, Los Angeles, CA, USA. goda@chem.s.u-tokyo.ac.jp.
18
Institute of Technological Sciences, Wuhan University, Wuhan, China. goda@chem.s.u-tokyo.ac.jp.
#
Contributed equally.
PMID:
35508736
DOI:
10.1038/s41592-022-01483-6
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Biomedical Research*